Radium-223 Dichloride in Combination With VEGF-Targeting Therapy in Advanced RCC With Bone Metastases
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Radium-223 Dichloride in Combination With Vascular Endothelial Growth Factor-Targeting Therapy in Advanced Renal Cell Carcinoma With Bone Metastases
Clin. Cancer Res 2018 May 30;[EPub Ahead of Print], RR McKay, D Bossé, KP Gray, MD Michaelson, KM Krajewski, HA Jacene, M Meghara Walsh, J Bellmunt, M Pomerantz, LC Harshman, TK ChoueiriFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Renal Cell Carcinoma Center of Excellence
Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.